SCHEMBL19106364

SCHEMBL19106364

c1ccc(-c2cccc(-c3cc(-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)cc(-c4nc(-c5ccccc5)c5sc6ccccc6c5n4)c3)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.37
▸ KMT2A Q03164 6/20 0.37
▸ MAPT P10636 4/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ HPGD P15428 4/20 0.37
▸ LMNA P02545 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ LIMK1 P53667 3/20 0.36
▸ NTSR1 P30989 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ PIM1 P11309 2/20 0.34
▸ PIM2 Q9P1W9 2/20 0.34
▸ PIM3 Q86V86 1/20 0.34
▸ TNKS O95271 2/20 0.34
▸ TNKS2 Q9H2K2 2/20 0.34
▸ KRAS P01116 1/20 0.34
▸ ADORA2A P29274 2/20 0.33
▸ ADORA1 P30542 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106359 0.99 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19106361 0.97 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19106365 0.97 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19106357 0.96 MEN1 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19106356 0.96 MEN1 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18158367 0.95 MEN1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18158335 0.95 MEN1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL18158337 0.95 MEN1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19106372 0.95 LIMK1 (0.39) MEN1KMT2AMAPTLMNALIMK1
SCHEMBL19106378 0.95 LIMK1 (0.39) MEN1KMT2AMAPTLMNALIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885MAPT 455/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885MAPT 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback